Covaxin booster dose enhances vaccine effectiveness against Delta, Omicron variants: ICMR The findings of the study have been published on bioRxiv, a pre-print server and have not been peer reviewed
NIH begins clinical trial evaluating second COVID-19 booster shots in adults The study, known as the COVID-19 Variant Immunologic Landscape (COVAIL) trial, is sponsored by the National Institute of Allergy…
Precaution dose to be of same COVID vaccine, private centres can levy up to Rs 150 as service charge The Centre announced that the precaution dose of COVID vaccines will be available to everyone aged above 18 years at the private…
Covaxin booster enhances antibody response against COVID variants: Study The study was conducted in January and the findings were published in the "Journal of Travel Medicine" on 24th March
42 per cent of those eligible currently unwilling to take the booster dose: LocalCircles Of those eligible, 14 per cent are unlikely to take it while 28 per cent of them are awaiting more information